CME Group (CME) – Analysts’ Recent Ratings Changes

A number of research firms have changed their ratings and price targets for CME Group (NASDAQ: CME):

• 10/28/2024 – CME Group had its price target raised by analysts at Piper Sandler from $240.00 to $250.00. They now have an “overweight” rating on the stock.
• 10/24/2024 – CME Group had its “sector perform” rating reaffirmed by analysts at Royal Bank of Canada. They now have a $235.00 price target on the stock.
• 10/24/2024 – CME Group had its price target raised by analysts at Oppenheimer Holdings Inc. from $245.00 to $258.00. They now have an “outperform” rating on the stock.
• 10/24/2024 – CME Group had its price target raised by analysts at Barclays PLC from $219.00 to $231.00. They now have an “equal weight” rating on the stock.
• 10/24/2024 – CME Group had its price target raised by analysts at Citigroup Inc. from $250.00 to $255.00. They now have a “buy” rating on the stock.
• 10/17/2024 – CME Group had its price target raised by analysts at Morgan Stanley from $210.00 to $233.00. They now have an “equal weight” rating on the stock.
• 10/14/2024 – CME Group had its price target raised by analysts at Oppenheimer Holdings Inc. from $228.00 to $245.00. They now have an “outperform” rating on the stock.
• 10/8/2024 – CME Group had its price target raised by analysts at Piper Sandler from $225.00 to $240.00. They now have an “overweight” rating on the stock.
• 10/8/2024 – CME Group was downgraded by analysts at Redburn Atlantic from a “buy” rating to a “neutral” rating. They now have a $244.00 price target on the stock.
• 10/7/2024 – CME Group had its price target raised by analysts at Barclays PLC from $209.00 to $219.00. They now have an “equal weight” rating on the stock.
• 10/3/2024 – CME Group had its price target raised by analysts at Bank of America Co. from $177.00 to $180.00. They now have an “underperform” rating on the stock.
• 10/3/2024 – CME Group had its price target raised by analysts at The Goldman Sachs Group, Inc. from $195.00 to $198.00. They now have a “sell” rating on the stock.
• 10/3/2024 – CME Group had its “sector perform” rating reaffirmed by analysts at Royal Bank of Canada. They now have a $235.00 price target on the stock.
• 10/3/2024 – CME Group had its price target raised by analysts at Citigroup Inc. from $240.00 to $250.00. They now have a “buy” rating on the stock.
• 9/27/2024 – CME Group is now covered by analysts at Royal Bank of Canada. They set a “sector perform” rating and a $235.00 price target on the stock.
• 9/26/2024 – CME Group is now covered by analysts at TD Cowen. They set a “hold” rating and a $221.00 price target on the stock.

CME Group Stock Down 3.1 %

NASDAQ:CME traded down $6.99 during trading hours on Wednesday, reaching $218.20. The company’s stock had a trading volume of 1,815,565 shares, compared to its average volume of 1,909,891. The company has a market capitalization of $78.57 billion, a P/E ratio of 22.94, a price-to-earnings-growth ratio of 5.62 and a beta of 0.55. CME Group Inc. has a 12 month low of $190.70 and a 12 month high of $230.36. The company has a debt-to-equity ratio of 0.09, a quick ratio of 1.02 and a current ratio of 1.02. The stock has a 50 day moving average price of $221.24 and a two-hundred day moving average price of $209.67.

CME Group (NASDAQ:CME) last announced its quarterly earnings data on Wednesday, October 23rd. The financial services provider reported $2.68 earnings per share for the quarter, beating analysts’ consensus estimates of $2.65 by $0.03. The firm had revenue of $1.58 billion for the quarter, compared to analyst estimates of $1.59 billion. CME Group had a net margin of 57.34% and a return on equity of 13.39%. The business’s quarterly revenue was up 18.4% compared to the same quarter last year. During the same period in the previous year, the company earned $2.25 earnings per share. Equities analysts predict that CME Group Inc. will post 10.23 EPS for the current fiscal year.

CME Group Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Wednesday, September 25th. Stockholders of record on Monday, September 9th were paid a $1.15 dividend. The ex-dividend date of this dividend was Monday, September 9th. This represents a $4.60 annualized dividend and a dividend yield of 2.11%. CME Group’s dividend payout ratio (DPR) is 48.37%.

Insider Buying and Selling

In other news, insider Timothy Francis Mccourt sold 1,374 shares of the firm’s stock in a transaction on Monday, October 28th. The shares were sold at an average price of $227.12, for a total value of $312,062.88. Following the sale, the insider now directly owns 7,275 shares in the company, valued at approximately $1,652,298. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. In other news, Director Bryan T. Durkin sold 7,593 shares of the business’s stock in a transaction that occurred on Friday, August 30th. The shares were sold at an average price of $214.59, for a total value of $1,629,381.87. Following the completion of the transaction, the director now owns 55,607 shares of the company’s stock, valued at $11,932,706.13. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, insider Timothy Francis Mccourt sold 1,374 shares of the business’s stock in a transaction that occurred on Monday, October 28th. The shares were sold at an average price of $227.12, for a total transaction of $312,062.88. Following the completion of the transaction, the insider now directly owns 7,275 shares of the company’s stock, valued at approximately $1,652,298. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 15,621 shares of company stock valued at $3,441,063. Company insiders own 0.30% of the company’s stock.

Hedge Funds Weigh In On CME Group

Several institutional investors have recently modified their holdings of the company. Wealth Enhancement Advisory Services LLC boosted its holdings in shares of CME Group by 21.2% during the second quarter. Wealth Enhancement Advisory Services LLC now owns 48,205 shares of the financial services provider’s stock worth $9,477,000 after purchasing an additional 8,443 shares during the period. Duality Advisers LP acquired a new stake in shares of CME Group during the 1st quarter worth about $1,455,000. SG Americas Securities LLC grew its holdings in CME Group by 312.2% during the 1st quarter. SG Americas Securities LLC now owns 56,768 shares of the financial services provider’s stock worth $12,222,000 after acquiring an additional 42,996 shares during the last quarter. Cetera Investment Advisers boosted its stake in shares of CME Group by 429.1% in the 1st quarter. Cetera Investment Advisers now owns 47,521 shares of the financial services provider’s stock valued at $10,231,000 after purchasing an additional 38,540 shares during the last quarter. Finally, Brookstone Capital Management raised its position in shares of CME Group by 12.2% in the 2nd quarter. Brookstone Capital Management now owns 30,555 shares of the financial services provider’s stock valued at $6,156,000 after acquiring an additional 3,325 shares during the period. Institutional investors own 87.75% of the company’s stock.

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.